ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
1.660 ^USD	-2.35%		0.00%	-8.79%

08-20	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI
08-18	Alzamend Neuro, Inc. Reports Phase 1/2A Lithium Imaging Data For AL001 At ISMRM Workshop	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

ec93a5475abfac756eb3852de.uKJVWljT-iCjBwiIx8AU2QZ_KCeNYBAob6_ZhzHnySc.--0dNQmhskTmRFLgv41RsndKeHT6F3VlAPiI40ednHDd7QUMEeq9RehjPA~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

23-04-12	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
21-12-27	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
21-10-01	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,466.27%
	LONZA GROUP AG					+20.94%
	REVOLUTION MEDICINES, INC.					+19.26%
	IQVIA HOLDINGS INC.					+3.18%
	BEONE MEDICINES AG					+20.63%
	CELLTRION, INC.					+42.28%
	ASCENDIS PHARMA A/S					+16.3%
	MEDPACE HOLDINGS, INC.					-1.6%
	EUROFINS SCIENTIFIC SE					-0.26%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					-2.6%
	Average					+158.44%
	Weighted average by Cap.					+16.45%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.660USD

Average target price

26.00USD

Spread / Average Target

+1,466.27%

High Price Target

26.00USD

Spread / Highest target

+1,466.27%

Low Price Target

26.00USD

Spread / Lowest Target

+1,466.27%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

The best tools reserved for subscribers to boost the performance of your investments!